Govt Job: For M.Pharm, M.Sc, Ph.D Job at National Institute of Pathology | Pay upto Rs. 58,280 pm

The Indian Registry of Pathology was established in 1965 under the auspices of the Indian Council of Medical Research (ICMR) in New Delhi, India as a centre for the collection and distribution of teaching materials in pathology.

The Registry was renamed in 1980 as the National Institute of Pathology (IOP) in view of its expanded scope and activities.

As per the need of the post-independence era when a large number of new medical colleges were coming up, IRP took up the initiative with the original aims and objectives of collection, classification, duplication and distribution of a representative spectrum of histopathological teaching material to several medical colleges, institutions, individual pathologists and clinicians.

Post : Research Associate

Online applications are invited in the prescribed format up to 05:00 PM by February 18, 2022 for filling up the following temporary posts in the project entitled “A pre-clinical in vivo study for evaluating anti-Biofilm FDA approved drugs in reducing treatment duration of anti-TB drugs” on contractual basis at, ICMR-National Institute of Pathology, as per the details provided below. After screening of applications, only shortlisted applicants will be called for interview.

No of Post : One

Age Limit : 35 Years

Consolidated pay : @ Rs.58280 p.m. consolidated

Duration : 1 Year

Essential Qualifications : PhD or M.Sc/M.Pharma /M.Tech having 3 years research, teaching and design and development experience.

Desirable : PhD in Biological Sciences/Pharmacology, preference shall be given to candidates who have prior experience of handling laboratory animals as evident from research publications.

How to apply

Applications should reach by E-mail to tbprojectsnip@gmail.com latest by February 18, 2022.

Apply with detailed CV in the format provided in this advertisement. National Institute of Pathology (ICMR) reserves the right to shortlist the candidates in case of receipt of large number of applications.

Only Shortlisted candidates will be intimated by E-mail regarding the date and time of interview. All candidates must bring CV, original certificates, letter of recommendation, and one set of self-attested photocopy of all certificates.

Candidates who are already working elsewhere should provide NOC from current employer at the time of interview.

No TA/DA will be paid for attending the interview. The appointment is terminable with one month’s notice from either side.

The selected candidate will have no claim for regular appointment under ICMR or continuation of his/her services in any other project.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore